Viewing Study NCT06672133


Ignite Creation Date: 2025-12-25 @ 3:04 AM
Ignite Modification Date: 2025-12-26 @ 1:43 AM
Study NCT ID: NCT06672133
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-11-05
First Post: 2024-11-01
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Adebrelimab Combined with Chemotherapy and Thoracic Radiotherapy for First-line Treatment of ES-SCLC
Sponsor: Jinming Yu
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-12
Start Date Type: ESTIMATED
Primary Completion Date: 2029-06
Primary Completion Date Type: ESTIMATED
Completion Date: 2029-12
Completion Date Type: ESTIMATED
First Submit Date: 2024-11-01
First Submit QC Date: None
Study First Post Date: 2024-11-04
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-11-02
Last Update Post Date: 2024-11-05
Last Update Post Date Type: ACTUAL